RAPID MICRO BIOSYSTEMS, INC. Fair Value Disclosure
| Fair value measurements as of December 31, 2024 | |||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Cash equivalents | $ | 13,721 | $ | — | $ | — | $ | 13,721 | |||||||||||||||
| Short-term investments | 33,821 | — | — | 33,821 | |||||||||||||||||||
| $ | 47,542 | $ | — | $ | — | $ | 47,542 | ||||||||||||||||
| Fair value measurements at December 31, 2023 | |||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Cash equivalents | $ | 20,306 | $ | — | $ | — | $ | 20,306 | |||||||||||||||
| Short-term investments | 62,625 | 5,143 | — | 67,768 | |||||||||||||||||||
| Long term investments | 2,911 | — | — | 2,911 | |||||||||||||||||||
| $ | 85,842 | $ | 5,143 | $ | — | $ | 90,985 | ||||||||||||||||
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.